This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: eradication therapy reduces gastric cancer risk in patients after endoscopic and operative resection for GC, as well as in non-GC patients with atrophic gastritis. AIM: eradication therapy in an East Asian population with a high incidence of GC. METHODS: ., ≤ 5 years and > 5 years). The heterogeneity and publication bias were also measured. CONCLUSION: eradication effectively reduced the risk of GC, irrespective of past history of previous cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sugimoto et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: